Table 2 Demographic Characteristics of the Sample
Mean (SD) or N (%) | ||||
|---|---|---|---|---|
Measure | All Participants (N = 38) | R:HP (n = 20) | HP:R (n = 18) | |
Age | Years; mean (SD) | 52.03 (11.40) | 52.70 (13.20) | 51.28 (9.32) |
Ethnicity | NZ European | 31 (81.6%) | 15 (75%) | 16 (89%) |
NZ Maori | 1 (2.6%) | 0 (0%) | 1 (5.6%) | |
NZ Maori/European | 5 (13.2%) | 5 (25%) | 0 (0%) | |
Pacific | 1 (2.6%) | 0 (0%) | 1 (5.6%) | |
Highest education | Secondary | 16 (42.1%) | 12 (60%) | 4 (21%) |
Tertiary | 15 (39.5%) | 6 (30%) | 9 (52.6%) | |
Post-graduate | 7 (18.4%) | 2 (10%) | 5 (26.3%) | |
Employment status | Full-time | 10 (26.3%) | 4 (20%) | 6 (36%) |
Part-time | 7 (18.4%) | 5 (25%) | 2 (11%) | |
Not working | 21 (55.3%) | 11 (55%) | 10 (55.6%) | |
Relationship status | Single | 7 (18.4%) | 3 (15%) | 4 (22%) |
Divorced/separated/widowed | 9 (23.7%) | 4 (20%) | 5 (28%) | |
Married/cohabitating | 22 (57.9%) | 13 (65%) | 9 (50%) | |
Cancer treatment | Chemotherapy only | 8 (21.1%) | 5 (25%) | 3 (16.7%) |
Hormone therapy only | 16 (42.1%) | 8 (40%) | 8 (44.4%) | |
Hormone and target therapy | 8 (21.1%) | 4 (20%) | 4 (22.2%) | |
Radiation and hormone therapy | 1 (2.6%) | 1 (5%) | 0 (0%) | |
No current medical cancer treatment | 5 (13.2%) | 2 (10%) | 3 (16.7%) | |
Time since diagnosis | Years; mean (SD) | 7.16 (7.18) | 7.15 (7.74) | 7.17 (6.72) |